Comprehensive Clinical Research Training Program

A Clinical Research is a systematic study for new drugs in human subjects to generate data

for discovering or verifying the Clinical, Pharmacological (including pharmacodynamics and

pharmacokinetic) or adverse Effects with the objective of determining safety and efficacy of

the new drug.

Clinical Research Industry has grown around the world at an unparalleled rate in the past few

years. It has opened up new vistas of employment for a large number of people. The Clinical

Trials market worldwide is worth over US$ 45 billion and the industry and the requirement of

potential candidates for various roles in the clinical research industry is increasing day by

day.

Clinical research business is gaining grounds in all parts of the world, hence new frontiers

have been achieved in the healthcare and pharma industry. Good enough, the clinical research

line of business is open to aspiring entrepreneurs who have the required qualifications and

experience to run such business in regulatory, clinical operations, Insurance and IT sector.

This industry is highly profitable even though level of profitability is dependent on our ability

to come up with breakthrough clinical research work.

Asia has become the fastest-growing pharmaceutical market globally. The region is home to

60% of the world’s population, offering tremendous market potential. This factor, together

with people’s growing ability to spend more on healthcare have all helped to attract an

increasing amount of pharmaceutical research and development activities to Asia.

A high population density in metropolitan areas combined with a large hospital infrastructure

allows individual study sites to recruit more patients more cost effectively while study

timelines can be kept on target. Whereas traditional study countries in Europe and America

have become expensive and may be saturated with clinical trials competing for the same

patient population.

Pharma giants like, Pfizer, J & J, GSK, Dr. Reddy’s, Sun pharma, Cipla, Lupin, Serum

Institute, Mylan, Sanofi Aventis etc are focus their R & D through clinical trials.

Regulatory authorities across all the countries are more vigilant while approving any new

molecule or drug into the market and they want to see how the product development went

through and how ethically and scientifically the clinical study has been conducted. This puts

the pharma Sponsors into major responsible role with greater man power to look over each

step with quality outcome.

Clinical research is an attractive industry for researchers in India because it foresees

enormous growth and job opportunities not only for trained medical, pharmaceutical, and

paramedical professionals but also for project management staff, regulatory authorities,

government, and the society at large